Retractable Technologies (RVP) Gains from Investment Securities (2010 - 2026)
Retractable Technologies (RVP) reported Gains from Investment Securities of $1.5 million for Q1 2026, little changed on a YoY basis from $1.5 million in Q1 2025, and up 517.1% quarter-over-quarter from -$354288.0 in Q4 2025.
Retractable Technologies (RVP) Gains from Investment Securities (2010 - 2026) Analysis & Trends
Retractable Technologies has reported Gains from Investment Securities for 17 years, with the latest figure at $1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities changed 0.34% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at -$351996.0 (down 105.97% YoY), and the FY2025 full-year result was -$346907.0, changed N/A from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $1.5 million, up from -$354288.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $10.4 million in Q4 2022, with the low at -$14.2 million in Q4 2023.
- Historically, Gains from Investment Securities has averaged $565201.5 across 5 years, with a median of $1.5 million in 2024.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities soared 675.53% — and 2025, when it plunged 300.5%.
- Retractable Technologies' Gains from Investment Securities stood at $10.4 million in 2022, then tumbled by 237.2% to -$14.2 million in 2023, then surged by 110.34% to $1.5 million in 2024, then sank by 124.07% to -$354288.0 in 2025, then jumped by 517.1% to $1.5 million in 2026.
- The last three Gains from Investment Securities figures came in at $1.5 million (Q1 2026), -$354288.0 (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Retractable Technologies | 19.78 Mn | -15.84 Mn | -838,408.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.48 Mn |
| Mar 31, 2026 | 1.48 Mn |
| Dec 31, 2025 | -354,288.00 |
| Dec 31, 2025 | -354,288.00 |
| Sep 30, 2025 | -2.95 Mn |
| Sep 30, 2025 | -2.95 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | -14.23 Mn |
| Dec 31, 2023 | -14.23 Mn |